Auvray, Marie <br/><br/>
Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  02 2019 
 - 33-40 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1879-0852 
<br/><br/><label>Standard No.: </label>10.1016/j.ejca.2018.11.031  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anilides--therapeutic use<br/>Antineoplastic Agents, Immunological<br/>Axitinib--therapeutic use<br/>Carcinoma, Renal Cell--drug therapy<br/>Female<br/>Humans<br/>Indazoles<br/>Ipilimumab<br/>Kidney Neoplasms--pathology<br/>Male<br/>Middle Aged<br/>Nivolumab<br/>Progression-Free Survival<br/>Protein Kinase Inhibitors--therapeutic use<br/>Pyridines--therapeutic use<br/>Pyrimidines--therapeutic use<br/>Receptors, Vascular Endothelial Growth Factor--antagonists & inhibitors<br/>Sulfonamides--therapeutic use<br/>Sunitinib--therapeutic use<br/>Treatment Failure